Abstract-Heart failure with normal ejection fraction occurs in elderly patients with hypertensive heart disease. We hypothesized that, in such patients, mineralocorticoid receptor activation accelerates the types of ventricular and vascular remodeling and dysfunction believed important in the transition to heart failure. We tested this hypothesis by administering deoxycorticosterone acetate (DOCA) without salt loading or nephrectomy to elderly dogs with experimental hypertension. Elderly dogs were made hypertensive by renal wrapping. After 5 weeks, dogs were randomly assigned to DOCA (1 mg/kg per day IM; old hypertensive [OH]ϩDOCA; nϭ11) or not (OH; nϭ11) for 3 weeks. At week 8, conscious echocardiography and hemodynamic assessment under anesthesia were performed. DOCA resulted in further increases in conscious blood pressure (PϽ0.05) without increases in cardiac output or diastolic volume. In the conscious state, effective arterial elastance (PϽ0.05) and systemic vascular resistance (Pϭ0.06) were increased, and systemic arterial compliance (PϽ0.05) was decreased in OHϩDOCA animals. After anesthesia, instrumentation, and autonomic blockade, blood pressure was lower, whereas left ventricular (LV) systolic elastance, LV diastolic stiffness, and ex vivo myofiber diastolic stiffness were increased in OHϩDOCA animals. LV collagen was increased in OHϩDOCA animals (PϽ0.05 for all), but LV mass, LV brain natriuretic peptide, and titin isoform profiles were not. Neither aortic stiffness nor aortic structure was altered in OHϩDOCA animals. These findings suggest that age and hypertensive heart disease enhance sensitivity to exogenous mineralocorticoid administration and that mineralocorticoid receptor activation could contribute to the transition to heart failure in elderly persons by promoting increases in LV diastolic and systolic stiffness. Key Words: heart failure Ⅲ hypertension Ⅲ collagen Ⅲ diastole H eart failure (HF) with normal ejection fraction (HFnlEF) comprises nearly half of the cases of HF and poses a substantial public health problem. 1 Advanced age and systemic hypertension are the dominant risk factors for HFnlEF. The presence of neurohumoral activation in HFnlEF and its role in mediating the transition from hypertensive heart disease (HHD) to HFnlEF has not been well studied. Mineralocorticoid (MC) receptor (MR) antagonism has been repeatedly demonstrated to reduce cardiac hypertrophy and fibrosis in experimental and human hypertension. 2,3 However, in young normal animals, the hypertensive and cardiac remodeling effects of experimental MC excess are dependent on concomitant salt loading (and unilateral nephrectomy). 2,4 The mechanisms whereby salt loading exacerbates the effects of exogenous MC administration on the heart and vasculature are unclear, and other factors present in HHD, 5 vascular disease, 6 or HF 7 may also sensitize the cardiovascular system to the adverse effects of exogenous MC excess. Indeed, a recent study showed that aldosterone levels correlate potently with mortality in HF regardle...